INVO Bioscience, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Bioscience, Inc. (trading symbol: INVO) on April 26, 2021, covering events occurring on April 21, 2021. The company is incorporated in Nevada and its common stock is registered on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on corporate governance changes.
Material Changes
The primary material change reported is the expansion of the Board of Directors:
- Appointment: On April 21, 2021, the Board appointed Rebecca Messina as a director.
- Board Composition: This appointment filled a vacancy created by a prior expansion in November 2020, bringing the total number of Board members to seven (7).
- Term: Ms. Messina will serve until her successor is duly elected and qualified.
Management Commentary and Background
The filing provides a professional background for the new director, Rebecca Messina:
- Current Role: Senior Advisor at McKinsey & Company (since 2019).
- Previous Experience: Global Chief Marketing Officer for Uber (2018-2019); Senior Vice President and Global Chief Marketing Officer for Beam Suntory (2016-2018); 22 years with The Coca-Cola Company in various leadership roles.
- Other Directorships: Vive Organics, Archer Boose, Make-A-Wish Foundation, Bartesian, and Mobile Marketing Association.
Investor Verification Checklist
- Verify the official press release dated April 26, 2021 (Exhibit 99.1) for additional details on the appointment.
- Confirm the current total number of Board members is seven.
- Review Ms. Messina's full biography and potential conflicts of interest via the company's proxy statements or subsequent filings.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.